vs

Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.

Medirom Healthcare Technologies Inc. is the larger business by last-quarter revenue ($21.1M vs $15.7M, roughly 1.3× CF BANKSHARES INC.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -21.3%, a 61.4% gap on every dollar of revenue. CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $-2.4K).

CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

CFBK vs MRM — Head-to-Head

Bigger by revenue
MRM
MRM
1.3× larger
MRM
$21.1M
$15.7M
CFBK
Higher net margin
CFBK
CFBK
61.4% more per $
CFBK
40.0%
-21.3%
MRM
More free cash flow
CFBK
CFBK
$18.2M more FCF
CFBK
$18.2M
$-2.4K
MRM

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CFBK
CFBK
MRM
MRM
Revenue
$15.7M
$21.1M
Net Profit
$5.7M
$-4.5M
Gross Margin
10.8%
Operating Margin
43.4%
-28.5%
Net Margin
40.0%
-21.3%
Revenue YoY
12.6%
Net Profit YoY
29.9%
EPS (diluted)
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFBK
CFBK
MRM
MRM
Q4 25
$15.7M
Q3 25
$15.5M
Q2 25
$15.6M
$21.1M
Q1 25
$14.1M
Q4 24
$14.0M
Q3 24
$13.1M
Q2 24
$12.6M
Q1 24
$12.2M
Net Profit
CFBK
CFBK
MRM
MRM
Q4 25
$5.7M
Q3 25
$2.3M
Q2 25
$5.0M
$-4.5M
Q1 25
$4.4M
Q4 24
$4.4M
Q3 24
$4.2M
Q2 24
$1.7M
Q1 24
$3.1M
Gross Margin
CFBK
CFBK
MRM
MRM
Q4 25
Q3 25
Q2 25
10.8%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
CFBK
CFBK
MRM
MRM
Q4 25
43.4%
Q3 25
17.5%
Q2 25
41.1%
-28.5%
Q1 25
39.5%
Q4 24
36.9%
Q3 24
40.4%
Q2 24
15.4%
Q1 24
30.9%
Net Margin
CFBK
CFBK
MRM
MRM
Q4 25
40.0%
Q3 25
15.1%
Q2 25
32.3%
-21.3%
Q1 25
31.4%
Q4 24
35.2%
Q3 24
32.2%
Q2 24
13.5%
Q1 24
25.2%
EPS (diluted)
CFBK
CFBK
MRM
MRM
Q4 25
$0.88
Q3 25
$0.36
Q2 25
$0.77
Q1 25
$0.68
Q4 24
$0.68
Q3 24
$0.65
Q2 24
$0.26
Q1 24
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFBK
CFBK
MRM
MRM
Cash + ST InvestmentsLiquidity on hand
$259.0M
$252.3K
Total DebtLower is stronger
$8.8M
Stockholders' EquityBook value
$184.4M
$1.6M
Total Assets
$2.1B
$52.0M
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFBK
CFBK
MRM
MRM
Q4 25
$259.0M
Q3 25
$272.4M
Q2 25
$275.7M
$252.3K
Q1 25
$241.0M
Q4 24
$235.3M
Q3 24
$233.5M
Q2 24
$241.8M
Q1 24
$236.9M
Total Debt
CFBK
CFBK
MRM
MRM
Q4 25
Q3 25
Q2 25
$8.8M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CFBK
CFBK
MRM
MRM
Q4 25
$184.4M
Q3 25
$179.3M
Q2 25
$177.0M
$1.6M
Q1 25
$172.7M
Q4 24
$168.4M
Q3 24
$164.0M
Q2 24
$159.6M
Q1 24
$158.0M
Total Assets
CFBK
CFBK
MRM
MRM
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
$52.0M
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.0B
Q1 24
$2.0B
Debt / Equity
CFBK
CFBK
MRM
MRM
Q4 25
Q3 25
Q2 25
5.55×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CFBK
CFBK
MRM
MRM
Operating Cash FlowLast quarter
$18.7M
$-2.3K
Free Cash FlowOCF − Capex
$18.2M
$-2.4K
FCF MarginFCF / Revenue
115.6%
-0.0%
Capex IntensityCapex / Revenue
3.1%
0.0%
Cash ConversionOCF / Net Profit
3.26×
TTM Free Cash FlowTrailing 4 quarters
$33.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CFBK
CFBK
MRM
MRM
Q4 25
$18.7M
Q3 25
$5.5M
Q2 25
$8.0M
$-2.3K
Q1 25
$2.2M
Q4 24
$14.2M
Q3 24
$-1.3M
Q2 24
$4.0M
Q1 24
$-1.2M
Free Cash Flow
CFBK
CFBK
MRM
MRM
Q4 25
$18.2M
Q3 25
$5.2M
Q2 25
$7.8M
$-2.4K
Q1 25
$2.2M
Q4 24
$13.9M
Q3 24
$-1.3M
Q2 24
$4.0M
Q1 24
$-1.2M
FCF Margin
CFBK
CFBK
MRM
MRM
Q4 25
115.6%
Q3 25
33.6%
Q2 25
50.3%
-0.0%
Q1 25
15.2%
Q4 24
99.6%
Q3 24
-9.9%
Q2 24
31.6%
Q1 24
-9.5%
Capex Intensity
CFBK
CFBK
MRM
MRM
Q4 25
3.1%
Q3 25
1.7%
Q2 25
0.7%
0.0%
Q1 25
0.4%
Q4 24
1.9%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
CFBK
CFBK
MRM
MRM
Q4 25
3.26×
Q3 25
2.34×
Q2 25
1.58×
Q1 25
0.50×
Q4 24
3.21×
Q3 24
-0.30×
Q2 24
2.35×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CFBK
CFBK

Segment breakdown not available.

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

Related Comparisons